Aclaris Therapeutics Inc (ACRS)
1.23
0.00 (0.00%)
USD |
NASDAQ |
Apr 18, 16:00
1.25
+0.02
(+1.63%)
After-Hours: 20:00
Aclaris Therapeutics Profit Margin (Quarterly): -8.49% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -8.49% |
| September 30, 2023 | -315.2% |
| June 30, 2023 | -1.58K% |
| March 31, 2023 | -1.11K% |
| December 31, 2022 | -356.4% |
| September 30, 2022 | -104.9% |
| June 30, 2022 | -1.34K% |
| March 31, 2022 | -1.29K% |
| December 31, 2021 | -1.52K% |
| September 30, 2021 | -1.27K% |
| June 30, 2021 | -995.7% |
| March 31, 2021 | -1.62K% |
| December 31, 2020 | -833.7% |
| Date | Value |
|---|---|
| September 30, 2020 | -735.6% |
| June 30, 2020 | -566.8% |
| March 31, 2020 | -1.11K% |
| December 31, 2019 | -1.70K% |
| September 30, 2019 | -5.63K% |
| June 30, 2019 | -5.63K% |
| March 31, 2019 | -2.97K% |
| December 31, 2018 | -2.18K% |
| September 30, 2018 | -2.93K% |
| June 30, 2018 | -849.2% |
| March 31, 2018 | -2.70K% |
| December 31, 2017 | -2.30K% |
| September 30, 2017 | -2.66K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-5.63K%
Minimum
Jun 2019
-8.49%
Maximum
Dec 2023
-1.46K%
Average
-1.11K%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| Aldeyra Therapeutics Inc | -- |
| Allakos Inc | -- |
| Regeneron Pharmaceuticals Inc | 33.77% |
| Puma Biotechnology Inc | 17.00% |
| CytomX Therapeutics Inc | 3.15% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -50.99% |
| Return on Assets | -38.95% |
| Return on Invested Capital | -50.99% |
| Gross Profit Margin (Quarterly) | 63.41% |
| Operating Margin (Quarterly) | -135.0% |
| Return on Net Operating Assets | -1.16K% |